Auxilium Pharmaceuticals Inc (AUXL.OQ)

AUXL.OQ on NASDAQ Stock Exchange Global Select Market

20.04USD
1 Aug 2013
Price Change (% chg)

$1.68 (+9.15%)
Prev Close
$18.36
Open
$19.58
Day's High
$20.93
Day's Low
$19.35
Volume
145,793
Avg. Vol
193,598
52-wk High
$26.55
52-wk Low
$13.88

AUXL.OQ

Chart for AUXL.OQ

About

Auxilium Pharmaceuticals, Inc. is a specialty biopharmaceutical company focuses on developing and marketing products to predominantly specialist audiences. It market two products: Testim testosterone gel and XIAFLEX (collagenase clostridium histolyticum). XIAFLEX is an injectable clostridial collagenase enzyme approved by the... (more)

Overall

Beta: 0.86
Market Cap (Mil.): $905.26
Shares Outstanding (Mil.): 49.31
Dividend: --
Yield (%): --

Financials

  AUXL.OQ Industry Sector
P/E (TTM): 11.45 37.93 37.76
EPS (TTM): 1.60 -- --
ROI: 20.65 19.48 18.76
ROE: 49.62 20.17 19.59
Search Stocks

Auxilium cuts sales outlook, expands urology business

- Auxilium Pharmaceuticals Inc reported a big drop in quarterly sales in the United States for both of its drugs, and said it acquired Actient Holdings LLC to bolster its urology business.

29 Apr 2013

UPDATE 2-Auxilium cuts sales outlook, expands urology business

April 29 - Auxilium Pharmaceuticals Inc reported a big drop in quarterly sales in the United States for both of its drugs, and said it acquired Actient Holdings LLC to bolster its urology business.

29 Apr 2013

Competitors

  Price Change
Eli Lilly & Co. (LLY.N) $53.29 +0.18
Actavis Inc (ACT.N) $135.52 +1.25
AbbVie Inc (ABBV.N) $45.69 +0.21

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: ValuEngine, Inc.
$25.00
Provider: Wright Reports
$472.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: S&P Capital IQ Quantitative Report
$69.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks